| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10633-012-9320-7 |
| P698 | PubMed publication ID | 22426576 |
| P2093 | author name string | Anne B Fulton | |
| Anne Moskowitz | |||
| Ronald M Hansen | |||
| Susan E Eklund | |||
| P2860 | cites work | Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings | Q28377661 |
| Amplification and kinetics of the activation steps in phototransduction | Q28708075 | ||
| Ocular component data in schoolchildren as a function of age and gender | Q30777092 | ||
| Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer | Q33234962 | ||
| Cone ERG responses in patients with Smith-Lemli-Opitz Syndrome (SLOS). | Q34110719 | ||
| Photopic ON- and OFF-pathway abnormalities in retinal dystrophies | Q34164016 | ||
| Development of the cone ERG in infants | Q34630148 | ||
| Severe persistent visual field constriction associated with vigabatrin | Q36242274 | ||
| Vigabatrin: 2008 update | Q37397004 | ||
| Reduced grating acuity associated with retinal toxicity in children with infantile spasms on vigabatrin therapy | Q37431696 | ||
| Electroretinogram changes in a pediatric population with epilepsy: is vigabatrin acting alone? | Q37431730 | ||
| The neurovascular retina in retinopathy of prematurity | Q37438201 | ||
| Essentials of photometry for clinical electrophysiology of vision | Q37760847 | ||
| Prevalence of visual field loss following exposure to vigabatrin therapy: A systematic review | Q37808724 | ||
| Rod vision is controlled by dopamine-dependent sensitization of rod bipolar cells by GABA. | Q38757734 | ||
| Longitudinal changes in photopic OPs occurring with vigabatrin treatment | Q41767611 | ||
| The Hospital for Sick Children, Toronto, Longitudinal ERG study of children on vigabatrin | Q41849869 | ||
| Changes in the electroretinogram resulting from discontinuation of vigabatrin in children | Q41849881 | ||
| Tsc2-Rheb signaling regulates EphA-mediated axon guidance | Q42075195 | ||
| Visual field loss in patients with refractory partial epilepsy treated with vigabatrin: final results from an open-label, observational, multicentre study | Q43257610 | ||
| The luminance-response function of the dark-adapted human electroretinogram | Q43495240 | ||
| Visual function loss from vigabatrin: effect of stopping the drug | Q43505004 | ||
| On-bipolar cells and depolarising third-order neurons as the origin of the ERG-b-wave in the RCS rat. | Q43574388 | ||
| Visual function is stable in patients who continue long-term vigabatrin therapy: implications for clinical decision making | Q43664148 | ||
| Vigabatrin effect on inner retinal function | Q43686221 | ||
| Augmented rod bipolar cell function in partial receptor loss: an ERG study in P23H rhodopsin transgenic and aging normal rats | Q43757186 | ||
| Cycloplegic refractions in healthy children aged 1 through 48 months | Q43799691 | ||
| Visual field constriction and electrophysiological changes associated with vigabatrin. | Q43985706 | ||
| Vigabatrin and retinal changes | Q43985708 | ||
| Visual field and electrophysiological abnormalities due to vigabatrin | Q43985711 | ||
| Electro-ophthalmological recovery after withdrawal from vigabatrin | Q43985714 | ||
| The effects of vigabatrin on electrophysiology and visual fields in epileptics: a controlled study with a discussion of possible mechanisms | Q43985718 | ||
| Rod photoreceptor function in children with mitochondrial disorders | Q44083466 | ||
| The photopic hill: a new phenomenon of the light adapted electroretinogram | Q44354080 | ||
| Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina | Q44489274 | ||
| Rod photoreceptor responses in children with Smith-Lemli-Opitz syndrome | Q44684817 | ||
| Examining visual field defects in the paediatric population exposed to vigabatrin | Q44718699 | ||
| Luminance dependence of neural components that underlies the primate photopic electroretinogram | Q44777423 | ||
| Contribution of cone photoreceptors and post-receptoral mechanisms to the human photopic electroretinogram | Q44780613 | ||
| In vivo studies of signaling in rod pathways of the mouse using the electroretinogram | Q45145661 | ||
| Visual fields in young children treated with vigabatrin. | Q46024496 | ||
| The ocular side effects of vigabatrin (Sabril): information and guidance for screening | Q46580856 | ||
| Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of gamma-acetylenic gaba and gamma-vinyl GABA, two irreversible GABA-T inhibitors | Q46931919 | ||
| ISCEV Standard for full-field clinical electroretinography (2008 update). | Q47217837 | ||
| Symptomatic and asymptomatic visual loss in patients taking vigabatrin. | Q50516870 | ||
| Rod phototransduction in retinitis pigmentosa: estimation and interpretation of parameters derived from the rod a-wave. | Q50771772 | ||
| Retinal nerve fiber layer thickness in vigabatrin-exposed patients. | Q51611825 | ||
| Effects of halothane on children's electroretinograms | Q51686054 | ||
| The development of scotopic sensitivity. | Q52168547 | ||
| The acuity card procedure: a rapid test of infant acuity. | Q52266135 | ||
| Phototransduction in human cones measured using the alpha-wave of the ERG. | Q52328573 | ||
| A quantitative account of the activation steps involved in phototransduction in amphibian photoreceptors | Q67503550 | ||
| Immunoreactive GABA transaminase within the pancreatic islet is localized in mitochondria of the B-cell | Q68162694 | ||
| Large sample population age norms for visual acuities obtained with Vistech-Teller Acuity Cards | Q72631017 | ||
| Separating the retinal electrophysiologic effects of vigabatrin: treatment versus field loss | Q74133781 | ||
| Measuring field loss in children administered vigabatrin: a problem in search of a solution | Q82635780 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 197-209 | |
| P577 | publication date | 2012-03-20 | |
| P1433 | published in | Documenta Ophthalmologica | Q15766028 |
| P1476 | title | Electroretinographic (ERG) responses in pediatric patients using vigabatrin | |
| P478 | volume | 124 |
| Q38752654 | A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience |
| Q87375327 | Changes in the ERG d-wave with vigabatrin treatment in a pediatric cohort |
| Q33628299 | Clinical trial of vigabatrin as adjunctive therapy in children with refractory epilepsy |
| Q50641951 | Does vigabatrin treatment for infantile spasms cause visual field defects? An international multicentre study. |
| Q84742209 | Epilepsy: Update to guidelines on treatment of infantile spasms |
| Q89208153 | ISCEV extended protocol for the photopic On-Off ERG |
| Q36314739 | Limiting Retinal Toxicity of Vigabatrin in Children With Infantile Spasms |
| Q50920259 | Progressive retinal degeneration in a girl with Knobloch syndrome who presented with signs of ocular albinism. |
| Q90625641 | Treatment of infantile spasms |
| Q53582038 | Vigabatrin can enhance electroretinographic responses in pigmented and albino rats. |
| Q34777907 | Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study. |
| Q89696134 | Vigabatrin-Induced Retinal Functional Alterations and Second-Order Neuron Plasticity in C57BL/6J Mice |
| Q28483144 | Vigabatrin-induced retinal toxicity is partially mediated by signaling in rod and cone photoreceptors |
Search more.